3jwe › Citations

Structural basis for human monoglyceride lipase inhibition.

Bertrand T, Augé F, Houtmann J, Rak A, Vallée F, Mikol V, Berne PF, Michot N, Cheuret D, Hoornaert C, Mathieu M
J Mol Biol 396 663-73 (2010)
Cited: 82 times
EuropePMC logo PMID: 19962385

Abstract

Monoglyceride lipase (MGL) is a serine hydrolase that hydrolyses 2-arachidonoylglycerol (2-AG) into arachidonic acid and glycerol. 2-AG is an endogenous ligand of cannabinoid receptors, involved in various physiological processes in the brain. We present here the first crystal structure of human MGL in its apo form and in complex with the covalent inhibitor SAR629. MGL shares the classic fold of the alpha/beta hydrolase family but depicts an unusually large hydrophobic occluded tunnel with a highly flexible lid at its entry and the catalytic triad buried at its end. Structures reveal the configuration of the catalytic triad and the shape and nature of the binding site of 2-AG. The bound structure of SAR629 highlights the key interactions for productive binding with MGL. The shape of the tunnel suggests a high druggability of the protein and provides an attractive template for drug discovery.

Reviews - 3jwe mentioned but not cited (2)

  1. Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders. Deng H, Li W. Acta Pharm Sin B 10 582-602 (2020)
  2. Monoglyceride lipase: Structure and inhibitors. Scalvini L, Piomelli D, Mor M. Chem Phys Lipids 197 13-24 (2016)

Articles - 3jwe mentioned but not cited (7)



Reviews citing this publication (17)

  1. FAT SIGNALS--lipases and lipolysis in lipid metabolism and signaling. Zechner R, Zimmermann R, Eichmann TO, Kohlwein SD, Haemmerle G, Lass A, Madeo F. Cell Metab 15 279-291 (2012)
  2. Lipolysis - a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores. Lass A, Zimmermann R, Oberer M, Zechner R. Prog Lipid Res 50 14-27 (2011)
  3. The metabolic serine hydrolases and their functions in mammalian physiology and disease. Long JZ, Cravatt BF. Chem Rev 111 6022-6063 (2011)
  4. Biochemistry and pathophysiology of intravascular and intracellular lipolysis. Young SG, Zechner R. Genes Dev 27 459-484 (2013)
  5. The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors. Savinainen JR, Saario SM, Laitinen JT. Acta Physiol (Oxf) 204 267-276 (2012)
  6. Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways. Ueda N, Tsuboi K, Uyama T. FEBS J 280 1874-1894 (2013)
  7. The Lid Domain in Lipases: Structural and Functional Determinant of Enzymatic Properties. Khan FI, Lan D, Durrani R, Huan W, Zhao Z, Wang Y. Front Bioeng Biotechnol 5 16 (2017)
  8. Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling. Grabner GF, Zimmermann R, Schicho R, Taschler U. Pharmacol Ther 175 35-46 (2017)
  9. Monoacylglycerol lipase - a target for drug development? Fowler CJ. Br J Pharmacol 166 1568-1585 (2012)
  10. Dynamic changes to the endocannabinoid system in models of chronic pain. Rani Sagar D, Burston JJ, Woodhams SG, Chapman V. Philos Trans R Soc Lond B Biol Sci 367 3300-3311 (2012)
  11. Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases-focusing on FAAH/MAGL inhibitors. Ren SY, Wang ZZ, Zhang Y, Chen NH. Acta Pharmacol Sin 41 1263-1271 (2020)
  12. Cholesterol metabolism: a potential therapeutic target in Mycobacteria. Abuhammad A. Br J Pharmacol 174 2194-2208 (2017)
  13. Chemical modulation of glycerolipid signaling and metabolic pathways. Scott SA, Mathews TP, Ivanova PT, Lindsley CW, Brown HA. Biochim Biophys Acta 1841 1060-1084 (2014)
  14. PUFA-derived endocannabinoids: an overview. Cascio MG. Proc Nutr Soc 72 451-459 (2013)
  15. The Lipolysome-A Highly Complex and Dynamic Protein Network Orchestrating Cytoplasmic Triacylglycerol Degradation. Hofer P, Taschler U, Schreiber R, Kotzbeck P, Schoiswohl G. Metabolites 10 E147 (2020)
  16. Roles and Molecular Mechanisms of Biomarkers in Hepatocellular Carcinoma with Microvascular Invasion: A Review. Zhao X, Wang Y, Xia H, Liu S, Huang Z, He R, Yu L, Meng N, Wang H, You J, Li J, Yam JWP, Xu Y, Cui Y. J Clin Transl Hepatol 11 1170-1183 (2023)
  17. Fluorescence-Based Enzyme Activity Assay: Ascertaining the Activity and Inhibition of Endocannabinoid Hydrolytic Enzymes. Ciuffreda P, Xynomilakis O, Casati S, Ottria R. Int J Mol Sci 25 7693 (2024)

Articles citing this publication (56)



Quick links